The objective of this proposal is to examine the relationship of the amphetamine (AMPH)-induced increase in striatal Ca2+-binding protein, calmodulin (CaM) to the expression of sensitization to AMPH. Repeated, intermittent treatment of humans and animals with AMPH leads to a lasting dopamine (DA)-related behavioral sensitization, paralleled by enhanced stimulus-induced DA release in rat striatum and nucleus accumbens. Repeated AMPH elicits an enduring withdrawal-dependent increase in rat striatal and limbic forebrain CaM. This proposal will test the hypothesis that an alteration of the content and/or functional activity of CaM parallels development and contributes to expression of AMPH-induced sensitization. In particular, I hypothesize that an increased CaM Content or phosphorylating activity in striatal synaptosomes contributes to the enhanced DA release in AMPH-sensitized rats through increased phosphorylation of synapsin I and neuromodulin.
The specific aims of this proposal are to: (I) Relate the increase in CaM to AMPH-induced sensitization by determining whether the AMPH-induced increase in CaM can be blocked by drug treatments (haloperidol, MK-801) known to block the development of behavioral sensitization to AMPH. (2) Determine whether acute and/or repeated AMPH elicits changes in endogenous phosphorylation of synapsin I in rat striatum using a phosphosynapsin I antibody directed against a CaM-Kinase II phosphorylated site. Parallel changes in activities or content of protein kinase C, CaM-Kinase II and protein phosphatases will be determined. (3) Investigate the ability of AMPH to enhance phosphorylation of neuromodulin and synapsin I and alter kinase and phosphatase activities in a synaptosomal preparation. The effect of various stimuli (AMPH, K+, 4-AP) on DA release in synaptosomes from AMPH-pretreated rats will be examined. (4) Investigate an involvement of postsynaptic CaM in sensitization by measuring changes in CaM content, CaM-binding proteins, CaM-Kinase II activity and content and PKC activity in three postsynaptic membrane preparations in striata from rats pretreated with saline or AMPH: a) sucrose-density purified postsynaptic membranes; b) purified postsynaptic densities and c) total and postsynaptosomal cytoskeletal fractions. AMPH-induced sensitization exhibits many characteristics possessed by other models of synaptic plasticity in which Ca2+ and CaM play a definite role. The fact that the increase in CaM exhibits characteristics that parallel aspects of behavioral sensitization, such as anatomical specificity, withdrawal- dependence and endurance, suggests a high demand for a Ca2+- and CaM- stimulated process in sensitization.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Project (R01)
Project #
5R01DA005066-05
Application #
2117404
Study Section
Drug Abuse Biomedical Research Review Committee (DABR)
Project Start
1989-03-01
Project End
1996-11-30
Budget Start
1994-12-01
Budget End
1995-11-30
Support Year
5
Fiscal Year
1995
Total Cost
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Pharmacology
Type
Schools of Medicine
DUNS #
791277940
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Gnegy, M E (1993) Calmodulin in neurotransmitter and hormone action. Annu Rev Pharmacol Toxicol 33:45-70
Gnegy, M E; Hong, P; Ferrell, S T (1993) Phosphorylation of neuromodulin in rat striatum after acute and repeated, intermittent amphetamine. Brain Res Mol Brain Res 20:289-98
Gnegy, M E; Hewlett, G H; Yee, S L et al. (1991) Alterations in calmodulin content and localization in areas of rat brain after repeated intermittent amphetamine. Brain Res 562:6-12
Sweet, S C; Gnegy, M E; Welsh, M J (1991) Presence of matrix-specific antibodies in affinity-purified polyclonal antibodies. J Immunol Methods 136:31-6
Roseboom, P H; Hewlett, G H; Gnegy, M E (1990) Repeated amphetamine administration alters the interaction between D1-stimulated adenylyl cyclase activity and calmodulin in rat striatum. J Pharmacol Exp Ther 255:197-203